Cytochrome P450 polymorphisms are associated with reduced warfarin dose

Surgery

Volumn 128, Issue 2, 2000, Pages 281-285

  Freeman, Bradley D ^a   Zehnbauer, Barbara A ^a   McGrath, Sean ^a   Borecki, Ingrid ^a   Buchman, Timothy G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C9; WARFARIN;

ADULT; AGED; ALLELE; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; METABOLIC INHIBITION; PRIORITY JOURNAL;

EID: 0033884635     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.107283     Document Type: Article

References (24)

1. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
2. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention
3. Home prothrombin time monitoring after the initiation of warfarin therapy
4. Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
5. Risk factors for complications of chronic anticoagulation
6. Anticoagulant, thrombolytic, and anti-platelet drugs
7. The role of CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
8. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes
9. Allelic and functional variability of cytochrome P4502C9
10. Genetic polymorphisms of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing antico-agulation therapy
11. Genetic association between sensitivity to warfarin and expression of CYP2C9*3
12. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
13. Interactions of warfarin with drugs and food
14. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer disease
15. Molecular basis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
16. Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
17. Thiopurine methyl-transferase genotype predicts therapy-limiting severe toxicity from azathioprine
18. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding
19. Pharmacogenetics and heart failure: A convergence with carvedilol
20. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
21. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
22. A second reported kindred with hereditary resistance to oral anticoagulant drugs
23. Microchip arrays put DNA on the spot
24. Factor V Leiden mutation in a patient with warfarin-associated skin necrosis